Valuation: Simulations Plus, Inc.

Market Cap 37Cr 32Cr 30Cr 27Cr 52Cr 3.56TCr 53Cr 355.83Cr 139.78Cr 1.74TCr 138.61Cr 135.57Cr 6TCr P/E 2026 *
43.5x
P/E 2027 * 39.9x
Enterprise Value 37Cr 32Cr 30Cr 27Cr 52Cr 3.56TCr 53Cr 355.83Cr 139.78Cr 1.74TCr 138.61Cr 135.57Cr 6TCr EV / Sales 2026 *
4.51x
EV / Sales 2027 * 4.28x
Free-Float
82.81%
Yield 2026 *
-
Yield 2027 * -
1 day-0.08%
1 week-0.57%
Current month-0.41%
1 month-0.03%
3 months+29.14%
6 months-10.30%
Current year+0.03%
1 week 18.22
Extreme 18.215
18.4
1 month 18.1
Extreme 18.1
18.68
Current year 11.09
Extreme 11.09
21.01
1 year 11.09
Extreme 11.09
21.01
3 years 11.09
Extreme 11.09
52.69
5 years 11.09
Extreme 11.09
67.59
10 years 7.68
Extreme 7.68
90.92
Manager TitleAgeSince
Chief Executive Officer 67 26/06/2018
Director of Finance/CFO 63 01/12/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 81 17/07/1996
Director/Board Member 58 03/12/2014
Chairman 76 17/12/2024
Date Insider Type Main position Quantity % Market Cap.
06/07/26 Sell

Executive/Senior Manager

-1,000 0.0050%
01/07/26 Sell

Founder

-4,177 0.0207%
16/06/26 Fiscal year

Executive/Senior Manager

22,050 0.1094%
Change 5-day change 1-year change 3-year change Capi.($)
-0.08%-0.57%+41.25%-61.60% 37Cr
+1.65%+4.14%-30.06%-4.50% 3.15TCr
+0.62%-8.64%-40.32%+195.94% 1.41TCr
-1.06%-1.90%-23.38%+69.11% 564.68Cr
-4.59%-5.88% - - 235.01Cr
+0.23%+2.85%+68.79%-34.28% 212.93Cr
-2.91%-13.10% - - 180.37Cr
+3.15%+1.69%-32.76% - 107.86Cr
+2.52%-8.46%+50.32%+109.11% 90Cr
-19.62%-22.87%-50.37%+169.37% 79Cr
Average -1.94%-2.81%-2.07%+63.31% 606.17Cr
Weighted average by Cap. +0.49%-2.19%-26.81%+56.79%

Financials

2026 *2027 *
Net sales 8.19Cr 7.16Cr 6.62Cr 6.07Cr 11Cr 788.92Cr 12Cr 79Cr 31Cr 385.25Cr 31Cr 30Cr 1.33TCr 8.63Cr 7.54Cr 6.97Cr 6.4Cr 12Cr 831.18Cr 12Cr 83Cr 33Cr 405.89Cr 32Cr 32Cr 1.4TCr
Net income 95.34L 83.33L 77.07L 70.72L 1.34Cr 92Cr 1.36Cr 9.19Cr 3.61Cr 45Cr 3.58Cr 3.5Cr 154.88Cr 1.02Cr 88.99L 82.3L 75.52L 1.43Cr 98Cr 1.45Cr 9.82Cr 3.86Cr 48Cr 3.82Cr 3.74Cr 165.4Cr
Net Debt - -
Logo Simulations Plus, Inc.
Simulations Plus, Inc. specializes in model-informed and artificial intelligence (AI)-accelerated drug development. The Company helps its clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through science-based software and consulting solutions. The Company’s segments include Software and Services. The Company's Software segment supports pharmaceutical research, development, and commercialization through simulation, modeling, and AI-driven prediction. Its main products include GastroPlus, ADMET Predictor, MonolixSuite, and others for disease modeling and training, as well as Pro-ficiency for clinical operations. Its Services segment includes advanced consulting services across the entire drug development lifecycle. Its scientists and engineers specialize in drug discovery, pharmacokinetics, pharmacodynamics, drug modeling, clinical trial data analysis, regulatory strategy, and medical communications.
Employees
213
Date Price Change Volume
17/26/17 $18.24 -0.08% 2,48,999
15/26/15 $18.25 +0.16% 2,07,915
14/26/14 $18.22 -0.16% 6,17,725
13/26/13 $18.25 +0.05% 3,94,365
10/26/10 $18.24 -0.55% 4,23,570
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
18.25USD
Average target price
17.25USD
Spread / Average Target
-5.48%

Quarterly revenue - Rate of surprise